Popularity #2,966Earnings are out
BlossomHill Therapeutics (BLSM)
Develops oral small-molecule cancer therapies for EGFR, CLK and KRAS targets.
$22.48
vs last close−2.77 (−10.97%)
Something off on this page? Send us feedback.
EPSReportedEstimate
———————Sep '26
Reported———————−$8.75
Estimate———————−$0.93
Surprise———————−844.9%
RevenueReportedEstimate
———————Sep '26
Reported————————
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.83 | — | — |
| Sep 2027 | −$0.83 | — | — |
| Jun 2027 | −$0.88 | — | — |
| Mar 2027 | −$0.91 | — | — |
| Dec 2026 | −$0.93 | — | — |
| Sep 2026 | −$0.87 | — | — |
| Sep 2026 | −$0.93 | −$8.75 | −844.9% |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.83 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.83 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.88 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.91 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.93 | — | — | $0 | — | — | — |
| Sep 2026 | −$0.87 | — | — | $0 | — | — | — |
| Sep 18, 2026 | −$0.93 | −$8.75 | −844.9% | — | — | — | −4.0% |